Singzyme platform
Superior bio-conjugates versatile Platform
- Built around the PAL enzymes
- Homogenous Product
- Choice of in-house linker chemistry
- Fully controllable Drug-to-Antibody Ratio
- The only platform with Dual Payload capability
Antibody discovery program
- Target identification
- First-in-class antibody discovery platform
- Antibody Engineering
- Bi-specific Drug conjugates
Linker Payload technology
- Proprietary Linker technology
- Unmatched chemical stability
- Ultra-high potency
CLEAR COMPETITIVE ADVANTAGE
A state of the Art technology
An unmatched conjugation platform:
- Ultra-fast enzymes (20,000 times faster activity)
- Full site specificity
- Unique Dual Payload capability